General Information of the Compound
| Compound ID |
CP0410024
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-N-[(2S)-1-(2-aminoethylamino)-1-oxo-3-phenylpropan-2-yl]-2-(3,4-dichlorophenyl)-4-(6-fluoro-1-methyl-2-oxospiro[3,1-benzoxazine-4,4'-piperidine]-1'-yl)-N-methylbutanamide;hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H41Cl3FN5O4
|
||||||||||||||||||
| Molecular Weight |
721.101
|
||||||||||||||||||
| Canonical SMILES |
Cl.CN([C@@H](Cc1ccccc1)C(=O)NCCN)C(=O)[C@H](CCN1CCC2(CC1)OC(=O)N(C)c1ccc(F)cc21)c1ccc(Cl)c(Cl)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H40Cl2FN5O4.ClH/c1-41(31(32(44)40-16-15-39)20-23-6-4-3-5-7-23)33(45)26(24-8-10-28(36)29(37)21-24)12-17-43-18-13-35(14-19-43)27-22-25(38)9-11-30(27)42(2)34(46)47-35;/h3-11,21-22,26,31H,12-20,39H2,1-2H3,(H,40,44);1H/t26-,31+;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GFZROQDSTNHYON-UGYRHGBJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01199, Neuromedin-K receptor
Protein ID: PT01410, Substance-P receptor